MOTS-C 10MG

MOTS-C (Mitochondrial Opa1 Targeting Signaling Peptide-C) is a synthetic peptide derived from mitochondrial proteins. This peptide is of interest within the academic and biochemical research communities for its potential role in mitochondrial function and cellular energetics.

Research Context

MOTS-C has emerged as a subject of study in the fields of mitochondrial biology and cellular metabolism. Research suggests that MOTS-C may influence mitochondrial biogenesis, oxidative stress responses, and cellular adaptations under various physiological and pathological conditions. Due to its potential impact on mitochondrial dynamics, MOTS-C has been explored in preclinical models for its possible implications in aging, metabolic diseases, and neurodegenerative research.

Research Overview

MOTS-C is a 15-amino acid peptide derived from human mitochondrial transcripts, specifically from the mitochondrial open reading frame 1 (MTORF1). Initial studies have indicated that MOTS-C may function as a regulator of mitochondrial function, potentially enhancing mitochondrial respiration and ATP production. While the mechanisms underlying its effects are still under investigation, MOTS-C has shown promise in modulating cellular energy homeostasis in various experimental settings.

Key Research Focus Areas

• Mitochondrial Biogenesis: Investigation into whether MOTS-C influences the expression of nuclear-encoded mitochondrial genes, such as those encoding PGC-1α, a key regulator of mitochondrial proliferation.
• Cellular Stress Responses: Exploration of MOTS-C’s role in modulating oxidative stress pathways, including the involvement of mitochondrial superoxide dismutase (SOD2) and other antioxidant defenses.
• Metabolic Adaptations: Examination of how MOTS-C may affect metabolic reprogramming in response to exercise, fasting, or other metabolic stressors.
• Neurodegenerative Research: Preliminary studies have examined the peptide’s potential neuroprotective effects in models of neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, due to its impact on mitochondrial function in neurons.

Important Safety and Compliance Notice

The following information is provided for research purposes only and does not constitute medical advice or a recommendation for use in human or animal studies. MOTS-C is a novel compound with limited human and preclinical safety data. Any research involving this peptide must be conducted in accordance with ethical standards, regulatory guidelines, and institutional review board approvals. This product is not intended for therapeutic, diagnostic, or cosmetic use and should only be handled by qualified researchers with appropriate expertise in peptide chemistry and biological safety protocols.

For research use only. Not for human or animal consumption.